Author

D. Wallace

Institutions: University of Rochester Medicine, University of Rochester

Observed institutions: University of Rochester Medicine, University of Rochester

OpenAlex ID: A5020128552

289 | Multicenter Real‐world Outcomes of Frontline Pola‐r‐chp in Treatment Naïve Dlbcl

2025 · S. K. Thiruvengadam, L. Chen, et al. · Hematological Oncology · 4

339 | Outcomes in an International Multicentre Study of 600 Patients With Cns Relapse of Large B Cell Lymphoma: Compartment of Relapse Is Prognostic

2025 · D. Baggio, S. Han, et al. · Hematological Oncology · 1

Outcomes of Autologous Transplant, Allogeneic Transplant, and Car T Cell Therapy in Tp53 Altered Mantle Cell Lymphoma: a Multi‐institution Retrospective Analysis

2023 · M. Messmer, A. Stack, et al. · Hematological Oncology

P1115: a Multicenter Phase 1/2 Trial of Eo2463, a Microbial-derived Peptide Therapeutic Vaccine, as Monotherapy and in Combination With Lenalidomide and Rituximab, for Treatment of Patients With Indolent Nhl

2022 · P. L. Zinzani, S. M. Ansell, et al. · HemaSphere

Works count: 4

Citation count: 5

H-index: 1

I10-index: